Paclitaxel, Carboplatin Plus Bevacizumab in Pretreated, Advanced or Metastatic Non Small Cell Lung Cancer

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2008
This trial will evaluate the efficacy and safety of paclitaxel, carboplatin and bevacizumab combination, administered biweekly, in patients with pretreated, advanced non small cell lung cancer.
Epistemonikos ID: efb573775195b7962b31b4ddc44e62ef070b51ae
First added on: May 05, 2024